Epigallocatechin-3-Gallate Attenuates Oxidative Stress and Inflammation in Obstructive Nephropathy via NF-κB and Nrf2/HO-1 Signalling Pathway Regulation

Basic and Clinical Pharmacology and Toxicology

Volumn 117, Issue 3, 2015, Pages 164-172

  Wang, Yanqiu ^a   Wang, Bowen ^a   Du, Feng ^a   Su, Xuesong ^a   Sun, Guangping ^a   Zhou, Guangyu ^a   Bian, Xiaohui ^a   Liu, Na ^b  

^a CHINA MEDICAL UNIVERSITY   (China)

^b Ordos Central Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; CREATININE; EPIGALLOCATECHIN GALLATE; HEME OXYGENASE 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LACTATE DEHYDROGENASE; TRANSCRIPTION FACTOR NRF2; BILIRUBIN; CATECHIN; HMOX1 PROTEIN, MOUSE; MEMBRANE PROTEIN; NFE2L2 PROTEIN, MOUSE;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DNA BINDING; INFLAMMATION; KIDNEY MASS; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; MEAN ARTERIAL PRESSURE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENAL PROTECTION; SHAM PROCEDURE; UREA NITROGEN BLOOD LEVEL; URETER OBSTRUCTION; ANALOGS AND DERIVATIVES; ANIMAL; C57BL MOUSE; CHEMISTRY; DISEASE MODEL; DRUG EFFECTS; ENZYMOLOGY; GEL MOBILITY SHIFT ASSAY; KIDNEY; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; URETERAL OBSTRUCTION;

MUS;

ANIMALS; BILIRUBIN; CATECHIN; DISEASE MODELS, ANIMAL; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HEME OXYGENASE-1; INFLAMMATION; KIDNEY; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; NF-E2-RELATED FACTOR 2; NF-KAPPA B; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; URETERAL OBSTRUCTION;

EID: 84938554463     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/bcpt.12383     Document Type: Article

References (44)

1. Ruggenenti P, Cravedi P, Remuzzi G. Mechanisms and treatment of CKD. J Am Soc Nephrol 2012;23:1917-28.
2. Schreiner GF, Harris KP, Purkerson ML, Klahr S. Immunological aspects of acute ureteral obstruction: immune cell infiltrate in the kidney. Kidney Int 1988;34:487-93.
3. Klahr S, Morrissey J. Obstructive nephropathy and renal fibrosis. Am J Physiol Renal Physiol 2002;283:F861-75.
4. Kinter M, Wolstenholme JT, Thornhill BA, Newton EA, McCormick ML, Chevalier RL. Unilateral ureteral obstruction impairs renal antioxidant enzyme activation during sodium depletion. Kidney Int 1999;55:1327-34.
5. Manucha W, Carrizo L, Ruete C, Molina H, Valles P. Angiotensin II type I antagonist on oxidative stress and heat shock protein 70 (HSP 70) expression in obstructive nephropathy. Cell Mol Biol 2005;51:547-55.
6. Xu B, Zhang YB, Li ZZ, Yang MW, Wang S, Jiang DP. Hydrogen-rich saline ameliorates renal injury induced by unilateral ureteral obstruction in rats. Int Immunopharmacol 2013;17:447-52.
7. Sugiyama H, Kobayashi M, Wang DH, Sunami R, Maeshima Y, Yamasaki Y et al. Telmisartan inhibits both oxidative stress and renal fibrosis after unilateral ureteral obstruction in acatalasemic mice. Nephrol Dial Transplant 2005;20:2670-80.
8. Hinz M, Scheidereit C. The IkappaB kinase complex in NF-kappaB regulation and beyond. EMBO Rep 2014;15:46-61.
9. Bolati D, Shimizu H, Yisireyili M, Nishijima F, Niwa T. Indoxyl sulfate, a uremic toxin, downregulates renal expression of Nrf2 through activation of NF-kappaB. BMC Nephrol 2013;14:56.
10. Yang SM, Chan YL, Hua KF, Chang JM, Chen HL, Tsai YJ et al. Osthole improves an accelerated focal segmental glomerulosclerosis model in the early stage by activating the Nrf2 antioxidant pathway and subsequently inhibiting NF-kappaB-mediated COX-2 expression and apoptosis. Free Radic Biol Med 2014;73:260-9.
11. Aminzadeh MA, Reisman SA, Vaziri ND, Khazaeli M, Yuan J, Meyer CJ. The synthetic triterpenoid RTA dh404 (CDDO-dhTFEA) restores Nrf2 activity and attenuates oxidative stress, inflammation, and fibrosis in rats with chronic kidney disease. Xenobiotica 2014;44:570-8.
12. Soetikno V, Sari FR, Lakshmanan AP, Arumugam S, Harima M, Suzuki K et al. Curcumin alleviates oxidative stress, inflammation, and renal fibrosis in remnant kidney through the Nrf2-keap1 pathway. Mol Nutr Food Res 2013;57:1649-59.
13. Kim JE, Lee MH, Nam DH, Song HK, Kang YS, Lee JE et al. Celastrol, an NF-kappaB inhibitor, improves insulin resistance and attenuates renal injury in db/db mice. PLoS One 2013;8:e62068.
14. Lecumberri E, Dupertuis YM, Miralbell R, Pichard C. Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy. Clin Nutr 2013;32:894-903.
15. Steinmann J, Buer J, Pietschmann T, Steinmann E. Anti-infective properties of epigallocatechin-3-gallate (EGCG), a component of green tea. Br J Pharmacol 2013;168:1059-73.
16. Riegsecker S, Wiczynski D, Kaplan MJ, Ahmed S. Potential benefits of green tea polyphenol EGCG in the prevention and treatment of vascular inflammation in rheumatoid arthritis. Life Sci 2013;93:307-12.
17. Mukhtar H, Ahmad N. Mechanism of cancer chemopreventive activity of green Tea. Proc Soc Exp Biol Med 1999;220:234-8.
18. Zhou P, Yu JF, Zhao CG, Sui FX, Teng X, Wu YB. Therapeutic potential of EGCG on acute renal damage in a rat model of obstructive nephropathy. Mol Med Rep 2013;7:1096-102.
19. Wilson HM, Chettibi S, Jobin C, Walbaum D, Rees AJ, Kluth DC. Inhibition of macrophage nuclear factor-kappaB leads to a dominant anti-inflammatory phenotype that attenuates glomerular inflammation in vivo. Am J Pathol 2005;167:27-37.
20. Mezzano SA, Barria M, Droguett MA, Burgos ME, Ardiles LG, Flores C et al. Tubular NF-kappaB and AP-1 activation in human proteinuric renal disease. Kidney Int 2001;60:1366-77.
21. Correa-Costa M, Semedo P, Monteiro AP, Silva RC, Pereira RL, Goncalves GM et al. Induction of heme oxygenase-1 can halt and even reverse renal tubule-interstitial fibrosis. PLoS One 2010;5:e14298.
22. Chung S, Yoon HE, Kim SJ, Kim SJ, Koh ES, Hong YA et al. Oleanolic acid attenuates renal fibrosis in mice with unilateral ureteral obstruction via facilitating nuclear translocation of Nrf2. Nutr Metab (Lond) 2014;11:2.
23. Chevalier RL, Thornhill BA, Chang AY, Cachat F, Lackey A. Recovery from release of ureteral obstruction in the rat: relationship to nephrogenesis. Kidney Int 2002;61:2033-43.
24. Mishima K, Maeshima A, Miya M, Sakurai N, Ikeuchi H, Hiromura K et al. Involvement of N-type Ca(2+) channels in the fibrotic process of the kidney in rats. Am J Physiol Renal Physiol 2013;304:F665-73.
25. Chen H, Sun F, Zhong X, Shao Y, Yoshimura A, Liu Y. Eplerenone-mediated aldosterone blockade prevents renal fibrosis by reducing renal inflammation, interstitial cell proliferation and oxidative stress. Kidney Blood Press Res 2013;37:557-66.
26. Wu WP, Chang CH, Chiu YT, Ku CL, Wen MC, Shu KH et al. A reduction of unilateral ureteral obstruction-induced renal fibrosis by a therapy combining valsartan with aliskiren. Am J Physiol Renal Physiol 2010;299:F929-41.
27. Hashem RM, Soliman HM, Shaapan SF. Turmeric-based diet can delay apoptosis without modulating NF-kappaB in unilateral ureteral obstruction in rats. J Pharm Pharmacol 2008;60:83-9.
28. Metcalfe PD, Leslie JA, Campbell MT, Meldrum DR, Hile KL, Meldrum KK. Testosterone exacerbates obstructive renal injury by stimulating TNF-alpha production and increasing proapoptotic and profibrotic signaling. Am J Physiol Endocrinol Metab 2008;294:E435-43.
29. Misseri R, Meldrum DR, Dinarello CA, Dagher P, Hile KL, Rink RC et al. TNF-alpha mediates obstruction-induced renal tubular cell apoptosis and proapoptotic signaling. Am J Physiol Renal Physiol 2005;288:F406-11.
30. Silverstein DM, Travis BR, Thornhill BA, Schurr JS, Kolls JK, Leung JC et al. Altered expression of immune modulator and structural genes in neonatal unilateral ureteral obstruction. Kidney Int 2003;64:25-35.
31. Dendooven A, Ishola DA Jr, Nguyen TQ, Van der Giezen DM, Kok RJ, Goldschmeding R et al. Oxidative stress in obstructive nephropathy. Int J Exp Pathol 2011;92:202-10.
32. Lawrence T. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol 2009;1:a001651.
33. Starkey JM, Haidacher SJ, LeJeune WS, Zhang X, Tieu BC, Choudhary S et al. Diabetes-induced activation of canonical and noncanonical nuclear factor-kappaB pathways in renal cortex. Diabetes 2006;55:1252-9.
34. Zheng L, Sinniah R, Hsu SI. In situ glomerular expression of activated NF-kappaB in human lupus nephritis and other non-proliferative proteinuric glomerulopathy. Virchows Arch 2006;448:172-83.
35. Sakai N, Wada T, Furuichi K, Iwata Y, Yoshimoto K, Kitagawa K et al. p38 MAPK phosphorylation and NF-kappa B activation in human crescentic glomerulonephritis. Nephrol Dial Transplant 2002;17:998-1004.
36. Cuzzocrea S, Rossi A, Pisano B, Di Paola R, Genovese T, Patel NS et al. Pyrrolidine dithiocarbamate attenuates the development of organ failure induced by zymosan in mice. Intensive Care Med 2003;29:2016-25.
37. Francescato HD, Costa RS, Scavone C, Coimbra TM. Parthenolide reduces cisplatin-induced renal damage. Toxicology 2007;230:64-75.
38. Kosaka T, Miyajima A, Kikuchi E, Horiguchi Y, Umezawa K, Ohigashi T et al. The novel NF-kappaB activation inhibitor dehydroxymethyl-epoxyquinomicin suppresses anti-Thy1.1-induced glomerulonephritis in rats. Nephron Exp Nephrol 2008;110:e17-24.
39. Tomita N, Morishita R, Lan HY, Yamamoto K, Hashizume M, Notake M et al. In vivo administration of a nuclear transcription factor-kappaB decoy suppresses experimental crescentic glomerulonephritis. J Am Soc Nephrol 2000;11:1244-52.
40. Zandi E, Rothwarf DM, Delhase M, Hayakawa M, Karin M. The IkappaB kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta, necessary for IkappaB phosphorylation and NF-kappaB activation. Cell 1997;91:243-52.
41. Pedruzzi LM, Stockler-Pinto MB, Leite M Jr, Mafra D. Nrf2-keap1 system versus NF-kappaB: the good and the evil in chronic kidney disease? Biochimie 2012;94:2461-6.
42. Mao L, Wang H, Qiao L, Wang X. Disruption of Nrf2 enhances the upregulation of nuclear factor-kappaB activity, tumor necrosis factor-alpha, and matrix metalloproteinase-9 after spinal cord injury in mice. Mediators Inflamm 2010;2010:238321.
43. -/- mice. Am J Pathol 2007;170:1820-30.
44. Jun CD, Kim Y, Choi EY, Kim M, Park B, Youn B et al. Gliotoxin reduces the severity of trinitrobenzene sulfonic acid-induced colitis in mice: evidence of the connection between heme oxygenase-1 and the nuclear factor-kappaB pathway in vitro and in vivo. Inflamm Bowel Dis 2006;12:619-29.